Anti-endothelial cell antibodies in patients with coronary atherosclerosis

Immunology Letters

Volumn 73, Issue 1, 2000, Pages 23-27

  George, Jacob ^a   Meroni, Pierluigi ^b   Gilburd, Boris ^a   Raschi, E ^b   Harats, Dror ^c   Shoenfeld, Yehuda ^a  

^a SHEBA MEDICAL CENTER   (Israel)

^b IRCCS   (Italy)

^c Lipid and Atherosclerosis Res Inst   (Israel)

Author keywords

Cell; Coronary atherosclerosis; E selectin

Indexed keywords

CELL ANTIBODY; ENDOTHELIAL CELL ANTIBODY; UNCLASSIFIED DRUG;

ADULT; AGED; ANGINA PECTORIS; ANTIBODY DETECTION; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; DISEASE ASSOCIATION; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0034600735     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-2478(00)00192-9     Document Type: Article

References (30)

1. Ross R. Atherosclerosis-an inflammatory condition. N. Eng. J. Med. 340:1999;115-126.
2. Libby P., Hansson G.K. Involvement of the immune system in human atherogenesis: current knowledge and unanswered questions. Lab. Invest. 64:1991;5-11.
3. Wick G., Schett G., Amberger A., Kleindienst R., Xu Q. Is atherosclerosis an immunologically mediated disease? Immunol. Today. 16:1995;27-33.
4. George J., Harats D., Gilburd B., Shoenfeld Y. Emerging cross-regulatory roles of immunity and autoimmunity in atherosclerosis. Immunol. Res. 155:1996;315-322.
5. Meroni P.L., D'Cruz D., Khamashta M., Youinou P., Hughes G.R.V. Anti-endothelial cell antibodies: only for scientists or for clinicians too? Clin. Exp. Immunol. 104:1996;199-202.
6. George J., Aron A., Levy Y., Ben-David A., Hojnik M., Renaudineau Y., Zonana-Nachach A., Youinou P., Harats D., Shoenfeld Y. Anti-cardiolipin, anti-endothelial-cell and anti-malondialdehyde-LDL antibodies in uremic patients undergoing hemodialysis: relationship with vascular access thrombosis and thromboembolic events. Hum. Antibodies. 9:1999;125-131.
7. Duun M.J., Crisp S.J., Rose M.L., Taylor R.M.R., Shenton B.K. Antiendothelial antibodies and coronary artery disease after cardiac transplantation. Lancet. 339:1992;1566-1570.
8. Cines D.B., Tomaski A., Tannenbaum S. Immune endothelial cell injury in heparin associated thrombocytopenia. N. Engl. J. Med. 316:1987;581-589.
9. Leung D.Y., Moake J.L., Havens P., Kim M., Pober S. Lytic antiendothelial cell antibodies in hemolytic uremic syndrome. Lancet. 23:1988;183-186.
10. Del Papa N., Guidali L., Spatola L., Bonara P., Borghi M.O., Tincani A., Balestrieri G., Meroni P.L. Relationship between anti-phospholipid and anti-endothelial cell antibodies III: beta 2 glycoprotein I mediates the antibody binding to endothelial membranes and induces the expression of adhesion molecules. Clin. Exp. Rheumatol. 13:1995;179-185.
11. Simantov R., LaSala J.M., Lo S.K., Gharavi A.E., Sammaritano L.R., Salmon J.E., Silverstein R.L. Activation of cultured vascular endothelial cells by antiphospholipid antibodies. J. Clin. Invest. 96:1995;2211-2219.
12. Del Papa N., Guidali L., Sironi M., Shoenfeld Y., Mantovani A., Tincani A., Balestrieri G., Radice A., Sinico R.A., Meroni P.L. Antiendothelial IgG antibodies from Wegener's granulomatosis bind to human endothelial cells in vitro and induce adhesion molecule expression and cytokine secretion. Arthritis Rheum. 39:1996;758-766.
13. Carvalho D., Savage C.O., Black C.M., Pearson J.D. IgG antiendothelial cell autoantibodies from scleroderma patients induce leukocyte adhesion to human vascular endothelial cells in vitro. Induction of adhesion molecule expression and involvement of endothelium derived cytokines. J. Clin. Invest. 97:(1):1996;111-119.
14. Del Papa N., Guidali L., Sala A., Buccellati C., Khamashta M.A., Ichikawa K., Koike T., Balestrieri G., Tincani A., Hughes G.R.V., Meroni P.L. Endothelial cells as target for antiphospholipid antibodies. Arthritis Rheum. 3:1997;551-561.
15. George J., Blank M., Levy Y., Meroni P.L., Damianovich M., Tincani A., Shoenfeld Y. Differential effects of anti-β2GPI antibodies on endothelial cells and on the manifestations of experimental antiphospholipid syndrome. Circulation. 97:1998;900-906.
16. Kollemeier A., Kreditor M., George J., Levy Y., Shoenfeld Y. Functional properties of anti-endothelial cell antibodies. Clin. Rev. Allergy Immunol. 16:1998;232-297.
17. Bordon A., Dueymes M., Levy Y., Jamin C., Ziporen L., Piette J.C., Shoenfeld Y., Youinou P. Anti-endothelial cell antibody binding makes negatively charged phospholipids accessible to antiphospholipid antibodies. Arthritis Rheum. 10:1998;1738-1747.
18. Bordon A., Dueymes M., Levy Y., Jamin C., Leroy J.P., Piette J.C., Shoenfeld Y., Youinou P. The binding of some human antiendothelial cell antibodies induces endothelial cell apoptosis. J. Clin. Invest. 101:1998;2029-2035.
19. Carvalho D., Savage C.O.S., Isenberg D., Pearson J.D. IgG anti-endothelial cell autoantibodies from patients with systemic lupus erythematosus or systemic vasculitis stimulate the release of two endothelial cell-derived mediators, which enhance adhesion molecule expression and leukocyte adhesion in an autocrine manner. Arthritis Rheum. 42:1999;631.
20. Del Papa N., Raschi E., Moroni G., Panzeri P., Borghi M.O., Ponticelli C., Tincani A., Balestrieri G., Meroni P.L. Anti-endothelial cell IgG fractions from systemic lupus erythematosus patients bind to human endothelial cells and induce a pro-adhesive and a pro-inflammatory phenotype in vitro. Lupus. 8:1999;1-7.
21. Blank M., Krause I., Goldkorn T., Praprotnik S., Livneh A., Langevitz P., et al. Monoclonal anti-endothelial cell antibodies from a patient with Takayasu arthritis activate endothelial cells from large vessels. Arthritis Rheum. 42:1999;1421-1432.
22. Muller Kobold A.C., van Wijk R.T., Franssen C.F.M., Molema G., Kallenberg C.G.M., Cohen Tervaert J.W. In vitro up-regulation of E-selectin and induction of interleukin-6 in endothelial cells by autoantibodies in Wegener's granulomatosis and mucroscopic polyangiitis. Clin. Exp. Rheumatol. 17:1999;433-440.
23. Coronary artery surgery study (CASS): a randomized trial of coronary artery bypass surgery. Circulation. 68:1983;939-950.
24. National heart, lung and blood institute coronary artery study. Circulation. 63:(Suppl 1):1981;I-41-20.
25. Damianovich M., Gilburd B., George J., Del Papa N., Afek A., Goldberg I., Kopolovic Y., Roth D., Barkai G., Meroni P.L., Shoenfeld Y. Pathogenic role of antiendothelial cell antibodies in vasculitis. J. Immunol. 156:1996;4946-4951.
26. Nityanand S., Bergmark C., de Faire U., Swedenborg J., Holm G., Lefvert A.K. Antibodies against endothelial cells and cardiolipin in young patients with peripheral atherosclerotic disease. J. Intern. Med. 237:1995;437-443.
27. Frostegard J., Wu R., Gillis-Haegerstrand C., Lemne C., de Faire U. Antibodies to endothelial cells in borderline hypertension. Circulation. 98:1998;1092-1098.
28. Del Papa N., Conforti G., Gambini D., La Rosa L., Tincani A., D'Cruz D., Khamashta M., Hughes G.R., Balestrieri G., Meroni P.L. Characterization of the endothelial surface proteins recognized by anti-endothelial antibodies in primary and secondary autoimmune vasculitis. Clin. Immunol. Immunopath. 70:1994;211-216.
29. Wheeler C.H., Collins A., Duun M.J., Crisp S.J., Yacoub M.H., Rose M.L. Characterization of endothelial antigens associated with transplant associated coronary artery disease. J. Heart Lung Transplant. 14:1995;S188-S197.
30. Smith J.D., Yacoub M.H., Rose M.L. Endothelial cell activation by sera containing HLA antibodies is mediated by interleukin-1. Transplantation. 66:1998;1229-1237.